Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Insight Genetics Inks Deal with St. Jude Children’s Research Hospital

Published: Monday, October 07, 2013
Last Updated: Monday, October 07, 2013
Bookmark and Share
Company announced it has entered into an exclusive, worldwide licensing agreement with the hospital for a genetic test known as the KIR/KIR-Ligand Assay.

The test helps to predict the success of bone marrow transplants by identifying the optimal bone marrow donor subtype. Use of the KIR/KIR-Ligand Assay has been shown to prevent the return of cancer in transplant recipients and reduce risk of death following bone marrow transplantation by about 60 percent. As part of the agreement, Insight Genetics will optimize the KIR/KIR-Ligand Assay for rapid, high-capacity use and make it broadly available to physicians and their patients as well as donor registries.

“When successful, bone marrow transplants can transform patients’ lives,” said Wing Leung, MD, PhD, Chair of St. Jude’s Department of Bone Marrow Transplantation and Cellular Therapy. “This is why it’s critical we do everything we can to ensure the best match between donor and recipient. The KIR/KIR-Ligand Assay has great potential in helping to identify the best transplant donors and improve outcomes for patients worldwide.”

The U.S. Health Resources and Services Administration estimates that each year more than 18,000 Americans are diagnosed with life-threatening illnesses for which bone marrow transplants are the best treatment option. There are millions of individuals registered as potential bone marrow donors, but effectively matching a patient in need of a transplant with the right donors is a difficult process.

According to the World Health Organization, when donors and recipients are optimally matched, bone marrow transplants can cure more than 90 percent of patients with blood and lymph cancers. The KIR/KIR-Ligand Assay has the potential to make the screening process more efficient and effective, greatly increasing the volume and quality of the donor-patient match. In fact, it is estimated that the test could assist in improving donor matches and increasing life expectancy for as many as 7,500 bone marrow transplant patients in the U.S. annually.

The KIR/KIR-Ligand test was developed by Dr. Leung, Dr. Rafijul Bari and colleagues at St. Jude as part of their research to determine the impact of variations in the KIR2DL1 gene. The group focused on forms of KIR2DL1 carried by natural killer (NK) cells, special immune cells that kill abnormal cells such as cancer cells. Their research found that some forms of KIR2DL1 in NK cells are more active than others, and NK cells carrying the stronger form of KIR2DL1 can destroy cancer cells more effectively than the NK cells with the less active form.

A study conducted by Bari, Leung and colleagues that was featured in the September 16 online version of the Journal of Clinical Oncology (JCO) showed that patients were much more likely to survive a transplant and significantly less likely to experience disease progression when bone marrow transplants came from donors whose NK cells included the stronger form of KIR2DL1.

“The KIR/KIR-Ligand technology developed at St. Jude offers enormous potential to improve the lives of patients who receive bone marrow transplants, and we’re looking forward to putting our assay development expertise to work to make it available for widespread clinical use around the world,” said David Hout, PhD, Vice President of Research and Development at Insight Genetics. “With this assay, we have the ability to type multiple donor samples simultaneously and generate results rapidly, all at a reduced cost compared to existing screening methods. This test will not only increase the efficiency with which transplants are performed but it also promises to help dramatically improve cure rates by optimally matching each donor and recipient.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Insight Genetics Announces Promotions for Two Team Members
Kasey Lawrence has been named Senior Technology Specialist, and Tyler Nielsen has been appointed Research Scientist.
Thursday, August 21, 2014
Insight Genetics and Vanderbilt-Ingram Cancer Center Partner
Research collaboration includes exclusive licensing agreement to commercialize a new genetic test that will improve treatment selection for breast cancer patients with poor prognosis.
Wednesday, March 05, 2014
Insight Genetics Awarded NCI Contract
Company receives Phase II Award to continue development of a companion diagnostic test for drugs targeting anaplastic lymphoma kinase.
Tuesday, January 07, 2014
Insight Genetics Launches Insight Molecular Labs
CLIA-certified laboratory offers diagnostic tests that identify specific cancer biomarkers.
Friday, December 13, 2013
Insight Genetics and National Cancer Institute Collaborate to Develop New Technologies for Clinical Trials
Insight Genetics has developed a diagnostic test that can more accurately determine if certain lung cancer patients will respond to targeted therapies.
Tuesday, April 02, 2013
Insight Genetics Promotes Four
Molecular diagnostics company builds expertise and depth in research, application and commercial development of companion diagnostics to improve cancer care.
Wednesday, February 13, 2013
Insight Genetics Awarded Qualifying Therapeutic Discovery Program Grant
Diagnostics Company Receives Funds to Advance Cancer Care.
Wednesday, November 17, 2010
Scientific News
Shedding Light on HIV Vaccine Design
Broadly speaking - Mathematical modelling of host-pathogen coevolution sheds light on HIV vaccine design.
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Oxygen Can Impair Cancer Immunotherapy in Mice
Researchers at NIH have discovered that the T cells contain a group of oxygen-sensing proteins which act to limit inflammation within the lungs.
Lab-on-a-Stick: Miniaturised Clinical Testing For Fast Detection Of Antibiotic Resistance
A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading.
Genetic Ancestry of Cultivated Strawberry Unravelled
UNH scientists constructed a linkage map of the seven chromosomes of the diploid Fragaria iinumae, which allows them to fill in a piece of the genetic puzzle about the eight sets of chromosomes of the cultivated strawberry.
Progress In Vaccination Against Vespid Venom
Researchers at the Helmholtz Zentrum München and the Technical University Munich have presented a method which facilitates a personalised procedure for wasp allergy sufferers.
New Drug Target for Inflammatory Disorders
Penn study finds enigmatic molecules maintain equilibrium between fighting infection and inflammatory havoc.
Emerging Model of Cancer
Cancer acts cooperatively, making individual decisions but acting in unison; this insight is being used to create a computer model of cancer.
Biological Barcodes Using CRISPR
Using genome editing tools, researchers are getting closer to understand differentiation of various cell types during development.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!